
Congress Can Act Now To Lower Drug Costs by Allowing Medicare To Negotiate Prices
Reforms to let Medicare negotiate prices, cap out-of-pocket costs for prescription drugs, and limit insulin cost-sharing would make lifesaving drugs more affordable.
Health care affordability is key for access to care and health equity. The Center for American Progress researches and supports policies that would lower health care costs for consumers and make health care more affordable and efficient. The following research and analyses outline opportunities to lower health care costs.
Reforms to let Medicare negotiate prices, cap out-of-pocket costs for prescription drugs, and limit insulin cost-sharing would make lifesaving drugs more affordable.
The House-passed bill expands insurance coverage, reduces prescription drug costs, and makes crucial investments in maternal and public health.
Value-based pricing aligns prescription drug prices to their clinical benefits, leading to lower spending and better health outcomes.
Key legislative proposals, including drug price negotiation and inflation caps, would save consumers and businesses millions of dollars.
The American Rescue Plan gives states additional flexibility to expand health coverage.
The United States needs comprehensive drug pricing reform that applies to all payers.
CAP’s drug pricing framework would empower Medicare and private payers to negotiate effectively for drug prices, backed by binding arbitration.